Here's why the Imricor Medical (ASX:IMR) share price is surging 8% today

What did the company update the ASX with?

| More on:
Doctor looking serious with arms crossed

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Imricor Medical Systems Inc. (ASX: IMR) share price is starting 2022 with a bang. This follows the medical device company's latest announcement that it has further expanded its geographical presence.

It sent Imricor shares soaring to $1.09, up 8.46%, on opening. At the time of writing, they've settled to trade at 1.045 apiece, up 3.98%.

What's driving the Imricor share price higher?

Investors are buying Imricor shares after the company announced it has expanded access for its iCMR ablation solutions.

In its release, Imricor advised that the Henry Dunant Hospital Centre in Athens, Greece will perform iCMR cardiac ablation procedures.

Constructed in 2000, the Henry Dunant Hospital Centre is one of the largest and most technologically advanced hospital centres in southeast Europe.

This is significant as it's Imricor strategic goal to grow the number of sites performing real-time iCMR cardiac ablation procedures in Europe.

An Equipment and Disposable Pricing Agreement was signed by both companies on 31 December.

Imricor will outfit an existing MR facility for iCMR procedures which are expected to begin in the first quarter of 2022. This will be under the direction of electrophysiologist Professor George Andrikopoulos.

The agreement will see a one-time purchase of capital equipment needed to outfit an iCMR lab at the site. It also includes Imricor's Advantage-MR EP Recorder/Stimulator as well as other third-party equipment sold by Imricor.

The term of the deal is valid for three years.

Imricor chair and CEO Steve Wedan commented:

We are very excited to work with Professor Andrikopoulos and his world-class team at Henry Dunant to bring iCMR cardiac ablations, for the first time, to patients in Greece.

More broadly, we are very pleased to see the acceleration in our rate of site adoption, adding four sites in the last quarter of 2021, and we remain focused on growing our installed base across Europe, as we enter 2022 with great enthusiasm.

About the Imricor share price

The Imricor share price has failed to take off in the past year, falling more than 50%. Despite being up today, its shares have been on a continuing decline.

Based on current share price levels, the company commands a market capitalisation of around $150 million.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

CSL share price leaping higher amid $1.9 billion funding news

ASX 200 investors are bidding up the CSL share price on Wednesday.

Read more »

Two happy scientists analysing test results.
Healthcare Shares

Mesoblast share price rockets 36% on breaking FDA news

ASX investors are sending the Mesoblast share price soaring following promising FDA news.

Read more »

a doctor in white coat and stethoscope stands in front of a building holding an electronic device in his hands.
Healthcare Shares

Guess which ASX 200 healthcare share is jumping 7% on a guidance update

This healthcare share is performing better than expected in FY 2024.

Read more »

a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
Earnings Results

Chemist Warehouse merger target Sigma reports 149% FY24 profit jump

This could be the last set of results from Sigma as we know it if its merger is approved.

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

1 ASX healthcare stock that looks severely undervalued

I think this stock looks too cheap to miss.

Read more »

Stethoscope with a piggy bank and hundred dollar notes.
Healthcare Shares

Own Medibank shares? Here's why it's a rewarding day for you

Shareholders are getting a healthy boost today.

Read more »

Health professional looking at a laptop.
Healthcare Shares

Are CSL shares a must-buy in March?

Let's see what analysts are saying about this high-quality company.

Read more »

A woman jumps for joy with a rocket drawn on the wall behind her.
Healthcare Shares

This ASX healthcare stock is up 72% on FDA news and 'historic moment'

Huge gains are been recorded by this stock on Tuesday. But why?

Read more »